drugset / Trial / NCT06650293

Effect of Vitamin D Supplementation as Adjuvant Therapy in Neonatal Jaundice in Combination With Phototherapy

NCT06650293

Completed 100 enrolled Muhammad Aamir Latif
RandomizedParallel-groupOpen-labelTreatment

Summary

Neonatal jaundice frequently occur during initial week of life. Neonatal jaundice is one of the leading causes of hospital admission and readmission. Some studies have suggested that the healthy newborns with hyperbilirubinemia outside the physiological range have notably reduced serum vitamin D levels. This deficiency is inversely associated with neonatal hyperbilirubinemia, suggesting that low vitamin D levels could be a potential risk factor for jaundice among neonates.

Timeline

Start
2022-05-10
Primary completion
2022-11-09
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 800 iu